Mednet Logo
HomeEndocrinologyQuestion

What are some advantages of Veligrotug over Tepezza for the treatment of thyroid eye disease?

1 Answers
Mednet Member
Mednet Member
Endocrinology · The University of Texas MD Anderson Cancer Center

Tepezza is FDA-approved and currently in use.

Veligrotug is being reviewed by the FDA. While the early released data suggest it is safe and improves thyroid eye disease (TED), before answering this question, we need to wait until the data are fully available and published. It is currently under FDA ...

Register or Sign In to see full answer